Gallium Ga 68-NeoB
Term · Oncology and biomedicine · MLC-T-ONC-013860
A radioconjugate consisting of a gastrin-releasing peptide receptor (GRPR) antagonist linked via the chelating agent, dodecanetetraacetic acid (DOTA), to the beta-emitting radioisotope gallium Ga 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration, gallium Ga 68-NeoB binds to GRPRs present on cancer cells. Upon binding, this radioconjugate can be used to quantify tumor uptake of NeoBOMB1 using PET/CT. GRPR, also known as bombesin receptor subtype 2, is a G protein-coupled receptor that is overexpressed in some cancer types.
| Identifier | MLC-T-ONC-013860 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 68Ga-DOTA-NeoBOMB1; gallium-68 DOTA-NeoBOMB1; 68Ga-NeoB; [68Ga]-NeoB; gallium Ga 68 NeoBOMB1 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013860",
"term": "Gallium Ga 68-NeoB",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate consisting of a gastrin-releasing peptide receptor (GRPR) antagonist linked via the chelating agent, dodecanetetraacetic acid (DOTA), to the beta-emitting radioisotope gallium Ga 68, with potential use in diagnostic imaging using positron emission tomography/computed tomography (PET/CT). Upon administration, gallium Ga 68-NeoB binds to GRPRs present on cancer cells. Upon binding, this radioconjugate can be used to quantify tumor uptake of NeoBOMB1 using PET/CT. GRPR, also known as bombesin receptor subtype 2, is a G protein-coupled receptor that is overexpressed in some cancer types.",
"synonyms": [
"68Ga-DOTA-NeoBOMB1",
"gallium-68 DOTA-NeoBOMB1",
"68Ga-NeoB",
"[68Ga]-NeoB",
"gallium Ga 68 NeoBOMB1"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gallium-ga-68-neob/"
}
Record 7,739 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.